MIB Agents | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

14,268 results for “MIB Agents”

Trials

View all 9859 →

Phase 2a MIB-626 vs. Placebo COVID-19

42 participants · First posted Sep 9, 2021

Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery

90 participants · First posted Jun 10, 2025

Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults

32 participants · First posted Feb 10, 2025

Drugs

View all 954 →

MIB-626

MIB-22

MIB-725

Organizations

View all 120 →

Ethos Technologies

United States

BeyondSpring

United States

Novo Nordisk AS

Sweden

News

View all 3335 →

UCLA's Dr. Theodore Scott Nowicki Receives $100,000 Hero Grant to Advance Armed CAR-T Therapy for Pediatric Osteosarcoma

Novel Immunotherapy OST-HER2 Shows Promise for Osteosarcoma Treatment, Featured in PBS Documentary

Metro International Biotech Initiates Phase 1a Trial of Novel NAD Booster MIB-725 for Age-Related Diseases

Page 1 of 1427